Identification of Multiple 5-HT4 Partial Agonist Clinical Candidates for the Treatment of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Identification of Multiple 5-HT4 Partial Agonist Clinical Candidates for the Treatment of Alzheimer’s Disease

Published:2012-10-05 Issue:21 Volume:55 Page:9240-9254
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Brodney Michael A.¹,Johnson David E.¹,Sawant-Basak Aarti¹,Coffman Karen J.¹,Drummond Elena M.¹,Hudson Emily L.¹,Fisher Katherine E.¹,Noguchi Hirohide¹,Waizumi Nobuaki¹,McDowell Laura L.¹,Papanikolaou Alexandros¹,Pettersen Betty A.¹,Schmidt Anne W.¹,Tseng Elaine¹,Stutzman-Engwall Kim¹,Rubitski David M.¹,Vanase-Frawley Michelle A.¹,Grimwood Sarah¹

Affiliation:

1. Groton Laboratories, Pfizer Global Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm300953p

Reference33 articles.

1. 2012 Alzheimer's disease facts and figures Alzheimer's Association ∗

2. The worldwide societal costs of dementia: Estimates for 2009

3. The Cholinergic Hypothesis of Geriatric Memory Dysfunction

4. The cholinergic hypothesis of Alzheimer's disease: a review of progress

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview on Diverse Biological Activities of Benzisoxazole Derivatives;Tailored Functional Materials;2022

2. Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer’s Disease;Journal of Medicinal Chemistry;2021-07-12

3. Understanding the Molecular Basis of 5-HT4 Receptor Partial Agonists through 3D-QSAR Studies;International Journal of Molecular Sciences;2021-03-30

4. Small Molecule Drugs for Treatment of Alzheimer’s Diseases Developed on the Basis of Mechanistic Understanding of the Serotonin Receptors 4 and 6;Serotonin and the CNS - New Developments in Pharmacology and Therapeutics [Working Title];2021-03-11

5. Classification models and SAR analysis on CysLT1 receptor antagonists using machine learning algorithms;Molecular Diversity;2021-02-03